Autoantibody to glutamate decarboxylase in a patient with spinocerebellar degeneration and Sjogren syndrome

Brain and Nerve

Volumn 50, Issue 2, 1998, Pages 177-180

  Ikeda, Junko ^a   Harada, Toshihide ^a   Kamei, Hidekazu ^a   Nakamura, Shigenobu ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti GAD antibody; Autoimmune disease; Cerebellar atrophy; Sjogren syndrome; Spinocerebellar degeneration

Indexed keywords

4 AMINOBUTYRIC ACID; AUTOANTIBODY; CORTICOSTEROID; GLUTAMATE DECARBOXYLASE;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; BRAIN ATROPHY; CASE REPORT; CEREBELLAR ATAXIA; DYSARTHRIA; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTRAVENOUS DRUG ADMINISTRATION; NEUROLOGICAL COMPLICATION; ORAL DRUG ADMINISTRATION; SJOEGREN SYNDROME; SPINOCEREBELLAR DEGENERATION;

AUTOANTIBODIES; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SJOGREN'S SYNDROME; SPINOCEREBELLAR DEGENERATIONS;

EID: 0031905002     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Martino GV, Tappaz ML, Braghi S, Dozio N, Canal N, Pozza G, Bottazzo GF, Grimaldi LME, Bosi E: Autoantibodies to glutamic acid decarboxylase detected by an immunotrapping enzyme activity assay : Relation to insulin-dependent diabetes mellitus and islet cell antibodies J Autoimmun 4: 915 -923, 1991
2. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P : Autoantibododies to GABA-ergic neurons and pancreatic β-cells in stiff-man syndrome. N Engl J Med 322: 1555-1560, 1990
3. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, Vicari AM : Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy and type-1 diabetes mellitus. N Engl J Med 318: 1012-1020, 1988
4. Kanazawa I, Kwak S, Sasaki H, Mizusawa H, Muramoto O, Yoshizawa K, Nukina N, Kitamura K, Kurisaki H, Sugita K : Studies on neurotransmitter markers and neuronal cell density in the cerebellar system in olivopontocerebellar atrophy and cortical cerebellar atrophy. J Neurol Sci 71 : 193-208, 1985
5. Ogawa N, Kuroda H, Ota Z, Yamamoto M, Otsuki S : Cerebrospinal fluid gamma-aminobutyric acid variations in cerebellar ataxia. Lancet 2: 215, 1982
6. Manyam NVB, Katz L, Hare TA, Gerber JC, Grossman MH : Levels of γ-aminobutyric acid in cerebrospinal fluid in various neurological disorders. Arch Neurol 37: 352-355, 1980
7. Solimena M, Piccolo G, Folli F, Fratino P, De Camillis P : Autoantibodies directed against gabaergic nerve terminals in a patient with idiopathic late-onset cerebellar ataxia and type 1B diabetes mellitus. Clin Neuropathol 7(suppl): 211, Abstract, 1988
8. Grimaldi LME, Martino G, Braghi S, Quattrini A, Furlan R. Bosi E, Comi G : Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol 34: 57-64, 1993
9. Honnorat J, Trouillas P, Thivolet C, Aguera M, Belin MF : Autoantibodies to glutamate decarboxylase In a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch Neurol 52: 462-468, 1995
10. Nakamura S, Kamei H, Mimori Y : Anti-GAD antibody in various neurological diseases. In : Tanaka C & Bowery NG (ed) : GABA: Receptors, Transporters and Metabolism, Birkhäuser Verlag, Basel, Switzerland. 1996, pp 45-52
11. Alexander GE, Provost TT, Stevens MB, Alexander EL : Sjögren syndrome : Central nervous system manifestations. Neurology 31: 1391-1396, 1981
12. Kaplan JG, Rosenberg R, Reinitz E, Buchbinder S, Schaumburg HH: Invited review : Peripheral neuropathy in Sjögren's syndrome. Muscle Nerve 13 : 570-579, 1990
13. Maida E, Kristoferitsch W : Zerebrale beteiligung bei einem fall von Sjögren-syndrom. Wien klin wochenschr 91: 337-339, 1979